Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Journal of Sun Yat-sen University(Medical Sciences) ; (6): 291-297, 2019.
Article in Chinese | WPRIM | ID: wpr-817757

ABSTRACT

@#【Objective】 To investigate the risk factors of long- term adverse cardiovascular outcomes for coronary artery disease patients after gastrointestinal bleeding and evaluate the value of AIMS65 score and Glasgow- Blatchford score(GBS) for predicating these outcomes among those patients.【Methods】 All coronary artery disease patients with gastrointestinal bleeding were enrolled in the study from 2014 to 2016. All demographic data and clinical data for hospitalized coronary artery disease patients with gastrointestinal bleeding were retrospectively analyzed and all patients were divided into two groups according to whether the main outcomes occurred or not in order to detect their clinical features , risk factors,and the prediction value of two score systems.【Results】Seventy patients showed the adverse cardiovascular outcomes among all patients. The area under the curve(AUC)that AIMS65 and GBS predicate the main outcomes were 0.59(P=0.035)and 0.51(P=0.039),respectively. The result of univariate analysis showed that age ,diabetes ,prior myocardial infarction ,hemoglobin ,prior proton- pump inhibitor use during hospital stay and blood transfusion were the risk factors. After multivariate analysis ,anemia ,high blood pressure and diabetes are independent risk factors.【Conclusions】 The GBS and AIMS65 both have a low specificity and sensitivity. Anemia ,high blood pressure and diabetes are independent risk factors of adverse cardiovascular outcomes after gastrointestinal bleeding.

2.
Chinese Journal of Oncology ; (12): 98-102, 2010.
Article in Chinese | WPRIM | ID: wpr-295172

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the antitumor immune response induced by dendritic cells vaccine coding AFPcDNA fragment with signal peptide (AFP(1)) and without signal peptide (AFP(2)), and to determine the inhibiting effect of the vaccine on the growth of hepatocarcinoma xenograft in Balb/c mice.</p><p><b>METHODS</b>pcDNA3.1/AFP(1) and pcDNA3.1/AFP(2) were transfected into dendritic cells (DCs) by calcium phosphate nanoparticles and became DCs vaccine. Mouse spleen lymphocytes were stimulated by AFP(1)/DC and AFP(2)/DC. A Balb/c mouse model bearing mouse HCC xenograft was established on the day 14 after transplantation. Forty mice were divided equally into AFP(2)/DC group, AFP(1)/DC group and plasmid control group. The treated mice received DCs vaccine and the same amount of control plasmid.</p><p><b>RESULTS</b>AFP(2)/DC stimulated T lymphocytel proliferation in vitro and improved CTL activity. The effects were better than AFP(1)/DC. The tumor-bearing mice injected intralesionally with AFP(1)/DC and AFP(2)/DC at a dose of 0.5 ml per mouse showed inhibition of tumor growth and prolongation of survival time. The tumor inhibition rate of the AFP(2)/DC group was 79.2% and the AFP(1)/DC group was 39.7% at 2 weeks after treatment. The tumor volume of AFP(2)/DC group was (726.7 +/- 298.2) mm(3), significantly smaller than the (1486.2 +/- 457.2) mm(3) of the AFP(1)/DC group and (2137.2 +/- 547.2) mm(3) of the plasmid control group (P < 0.05). The mean survival time of mice in the AFP(2)/DC group [(58.5 +/- 4.2) d] and AFP(1)/DC group [(45.2 +/- 4.8) d] were significantly longer than that of plasmid control group [(30.6 +/- 6.2) d, P < 0.05]. Bax-positive cell percentage was increased in the xenografts of AFP(2)/DC-treatment group compare with that of plasmid control group.</p><p><b>CONCLUSION</b>AFP(2)/DC and AFP(1)/DC vaccines show evident inhibiting effect on the growth of H22 xenograft in Balb/c mice through inducing efficient and specific immune response against the hepatocarcinoma cells.</p>


Subject(s)
Animals , Male , Mice , Calcium Phosphates , Pharmacology , Cancer Vaccines , Allergy and Immunology , Cell Line, Tumor , Cell Proliferation , DNA, Complementary , Genetics , Allergy and Immunology , Dendritic Cells , Allergy and Immunology , Immunization , Liver Neoplasms, Experimental , Pathology , Mice, Inbred BALB C , Nanoparticles , Neoplasm Transplantation , Peptide Fragments , Spleen , Cell Biology , T-Lymphocytes , Pathology , T-Lymphocytes, Cytotoxic , Allergy and Immunology , Transfection , alpha-Fetoproteins , Genetics , Allergy and Immunology
3.
Chinese Journal of Gastrointestinal Surgery ; (12): 210-212, 2010.
Article in Chinese | WPRIM | ID: wpr-259307

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical features of Crohn disease according to the Montreal classification.</p><p><b>METHODS</b>Clinical data of 43 surgical patients with Crohn disease (surgical group) and 125 non-surgical patients with Crohn disease (non-surgical group) were retrospectively analyzed and compared between two groups. The Montreal classification was used.</p><p><b>RESULTS</b>In the surgical group, 28 patients (65.1%) were A2, 14 (32.6%) were A3 and only one was A1, which was not significantly different as compared to the non-surgery group. The proportions of L1, L2, L3, and L4 subtype in the surgical group were 41.9%, 25.6%, 30.2%, and 2.3%, respectively, which was not significantly different as compared to that in the non-surgery group. In the surgical group,B1 disease was found in 1 case (2.3%), B2 in 26 cases (60.5%), and B3 in 16 cases (37.2%), while in the non-surgical group, B1 was found in 79 cases (63.2%), B2 in 44 cases (35.2%) and B3 in 2 cases (1.6%). Differences were significant between two groups in disease behavior (P=0.001, P=0.004, P=0.001).</p><p><b>CONCLUSIONS</b>Most surgical patients of Crohn disease are A2. L1 and L3 are the main lesion location. As disease behavior, B2 and B3 are the main reasons for operation.</p>


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Young Adult , Crohn Disease , Classification , Pathology , General Surgery , Reference Standards , Retrospective Studies
4.
Journal of Central South University(Medical Sciences) ; (12): 341-346, 2007.
Article in Chinese | WPRIM | ID: wpr-813880

ABSTRACT

OBJECTIVE@#To observe the therapeutic effect of Bacillus acidi lactici on Helicobacter Pylori (Hp) infectious gastritis in Balb/c mouse model so as to explore a possible non-antibiotic treatment for Hp.@*METHODS@#To establish a Balb/c mouse model with Hp infectious gastritis through inoculation of mankind Hp,32 Balb/c mice infected by Hp were randomly divided into 4 groups:Group 1(PPI trigeminy treatment group),Group 2 (Bacillus acidi lactici CL22 treatment group),Group 3 (Bacillus acidi lactici CL24 treatment group),and Group 4 (normal saline control group). Intragastric administration was given continuously for 10 days. Another 8 normal mice were chosen as Group 5(blank control group). All mice were killed after 4 weeks since last intragastric administration. Hp was detected by rapid urease test,Giemsa dying, and bacterial culture,and histopathologic changes in the gastric mucosa of mice were determined by H-E staining.@*RESULTS@#There were significant differences in pathohistologic scores in sinus ventriculi among the 5 groups (F = 7.932, P = 0.000). The scores in Group 1, Group 2, Group 3, and Group 5 were obviously lower than those in Group 4 (P 0.05). The pathohistologic score in Group 3 was obviously higher than that in Group 5 (P 0.05). There was significant difference in Hp eradication rates in sinus ventriculi among the 5 groups (chi2 = 16.923, P=0.002). The Hp eradication rates in Group 1 and 2 were obviously lower than those in Group 4 (P 0.05). There also were significant differences in Hp eradication rate in corpus ventriculi among the 5 groups (chi2 = 14.295, P=0.006). Of them, Group 1 and Group 2 were higher than Group 4 (P 0.05).@*CONCLUSION@#Bacillus acidi lactici strain CL22 can effectively inhibit and eradicate Hp in Balb/c mouse model with Hp infectious gastritis in vivo. The therapeutic effect of Bacillus acidi lactici strain CL22 is equal to PPI + antibiotics and could be another choice of nonjantibiotic treatment for Hp.


Subject(s)
Animals , Female , Male , Mice , Antibiosis , Physiology , Gastritis , Microbiology , Helicobacter Infections , Microbiology , Therapeutics , Helicobacter pylori , Lactic Acid , Chemistry , Lactobacillus , Metabolism , Physiology , Mice, Inbred BALB C , Random Allocation
5.
Journal of Central South University(Medical Sciences) ; (12): 684-689, 2007.
Article in Chinese | WPRIM | ID: wpr-813816

ABSTRACT

OBJECTIVE@#To evaluate the effect of herceptin(trastuzumab) plus adjuvant chemotherapy on the prognosis of patients with human epithelial growth factor receptor 2 (HER2) positive early-stage breast cancer by Meta-analysis.@*METHODS@#Search all of randomized clinical trials (RCTs) on herceptin plus adjuvant chemotherapy for HER2 positive early-stage breast cancer in MEDLINE, EMBase, Cochrane library, Clinical Trails, ASCO Conference data, CHKD, Wanfang Database, VIP information, scholar.google.com and SIGLE. A Meta-analysis was carried out by collecting information based on the inclusion and exclusion criteria from all papers available.@*RESULTS@#The Meta-analysis included 4 trials. A total of 9116 patients were included in the analysis(4555 in the study group and 4561 in the control group). There were statistical differences between the study group(herceptin plus adjuvant chemotherapy) and the control group(adjuvant chemotherapy) in the disease-free survival rate [relative risk(RR)=1.08, 95% CI, 1.06-1.09, P<0.001], the overall survival rate(RR=1.01, 95% CI, 1.01-1.02, P=0.0003), the distant recurrence rate(RR=0.49, 95% CI, 0.42-0.57, P<0.001), and the cardiac events rate (RR=3.93,95% CI, 1.03-15.06, P=0.05).@*CONCLUSION@#Herceptin plus adjuvant chemotherapy can improve the disease-free survival rate and the overall survival rate, decrease distant recurrence rate of patients with HER2 positive early-stage breast cancer, but may cause heart toxicity, especially when combined with anthracycline (doxorubicin).


Subject(s)
Female , Humans , Antibodies, Monoclonal, Humanized , Therapeutic Uses , Breast Neoplasms , Drug Therapy , Genetics , Metabolism , Chemotherapy, Adjuvant , Prognosis , Receptor, ErbB-2 , Genetics , Trastuzumab
6.
Chinese Journal of Digestion ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-683514

ABSTRACT

Objective To investigate the effect of bifidobacteria on dextran sulphate sodium(DSS)- induced acute ulcerative colitis in mice.Methods Thirty BALB/C mice were randomly divided into nor- mal control group (n=10),0501 strain group (n=10) and c122 strain group (n=10).Fifty BALB/ C mice received 5% dextran sulphate sodium(DSS) for 7 days to induce ulcerative colitis.The mice were then divided to model group,negative control group(perfused with 0.9 NaCl solution ),positive control group(perfused with SASP of 20 mg/ml),DSS + 0501 strain group(perfused with 1?10~9 CFU/ml bifidobacteria 0501 strain solution and DSS + c122 strain group (perfused with 1?10~9 CFU/ml bifidobacteria c122 strain solution).All mice were sacrificed 9 days later.The colon specimens were measure by histoehemical staining with H-E.The expressions of interleukin-10 (IL-10) and its protein were detected by RT-PCR and immunohistochemistry respectively.Results The degree of colon inflam- mation in mice both in DSS+ 0501 strain and DSS+ c122 strain groups were aggravated and expressions of IL-10 mRNA and protein were reduced compared to model group.No colon inflammation was found in 0501 strain and c122 strain groups.Conclusion Some strain of bifidobaeteria may aggravate colon in- flammation in mice when mucosal harrier is destroyed.

SELECTION OF CITATIONS
SEARCH DETAIL